|type= vaccine/combo/mab/blank

all/check

blank

IUPAC

mab

Purge mab = data10; source=data11, target=data12 (freetext)

 | mab = Whole antibody
 | fab = [[Fab fragment]]
 | f(ab')2 = [[F(ab')2 fragment|F(ab')<sub>2</sub> fragment]]
 | fab' = [[Fab' fragment]]
 | scfv = [[Single-chain variable fragment]]
 | discfv = Di-[[single-chain variable fragment]]
 | sdab = [[Single domain antibody]]
 | 3funct = [[Trifunctional antibody]]
 | clfab = [[Chemically linked Fab]]
 | bite = [[Bi-specific T-cell engager]]
 | ?

| label11 = [[Monoclonal antibody#Production|Source]]
|  data11 = {{#ifeq: {{{type|}}} | mab | {{#switch: {{lc:{{{source|}}}}}
 | =
 | a = [[Rat]]
 | e = [[Hamster]]
 | i = [[Primate]]
 | o = [[Mouse]]
 | u = [[Human]]
 | xi/a = [[chimeric antibody|Chimeric]] ([[rat]]/[[human]])
 | xi/e = [[chimeric antibody|Chimeric]] ([[hamster]]/[[human]])
 | xi/i = [[chimeric antibody|Chimeric]] ([[primate]]/[[human]])
 | xi/o = [[chimeric antibody|Chimeric]] ([[mouse]]/[[human]])
 | xi = [[chimeric antibody|Chimeric]]
 | zu/a = [[Humanized]] (from [[rat]])
 | zu/e = [[Humanized]] (from [[hamster]])
 | zu/i = [[Humanized]] (from [[primate]])
 | zu/o = [[Humanized]] (from [[mouse]])
 | zu = [[Humanized]]
 | xizu/a = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid ([[rat]]/[[human]])
 | xizu/e = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid ([[hamster]]/[[human]])
 | xizu/i = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid ([[primate]]/[[human]])
 | xizu/o = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid ([[mouse]]/[[human]])
 | xizu = [[chimeric antibody|Chimeric]]/[[humanized]] hybrid
 | axo = [[Rat]]/[[mouse]] hybrid
 | {{{source|}}} [[:Category:Drugboxes with unformatted antibody source]]

combo

vaccine

|vaccin_type=

 |killed |inactivated = Killed/Inactivated
 |attenuated = [[Attenuated virus]]
 |live = Live bacteria
 |toxoid = [[Toxoid]]
 |subunit = Subunit
 |protein subunit |protein = [[Protein subunit]]
 |conjugate=[[Conjugate vaccine]]
 |recombinant = [[Recombinant DNA|Recombinant Vector]]
 |dna = [[DNA vaccination]]
 | ?

TITLE tests (drug_name, INN)

Licence

Purge

Side by side comparison

{{ Infobox drug}}

{{ Infobox drug/sandbox}}

Infobox drug/testcases8 INN: Linezolid Clinical data Pronunciation /njuːˈmoʊniə/ Trade names Linospan, Zyvox, Zyvoxam, Zyvoxid Other names Lenzomore AHFS/ Drugs.com Monograph MedlinePlus a602004 License data EU  EMA:  by INN US  DailyMed:  Linezolid US  FDA:  Linezolid Pregnancy category AU: C Dependence liability High Addiction liability Low Routes of administration Intravenous infusion, oral ATC code J01XX08 ( WHO) Pharmacokinetic data Bioavailability ~100% (oral) Protein binding Low (31%) Metabolism Hepatic (50–70%, CYP not involved) Metabolites some stuff Onset of action 1 hr Elimination half-life 4.2–5.4 hours (shorter in children) Duration of action 1 to 3 hr Excretion Nonrenal, renal, and fecal Identifiers IUPAC name (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide CAS Number 165800-03-3 Y PubChem CID 441401 IUPHAR/BPS 1234 DrugBank DB00601 ChemSpider 390139 Y UNII ISQ9I6J12J KEGG D00947 Y ChEMBL ChEMBL126 Y NIAID ChemDB 070944 PDB ligand ZLD ( PDBe, RCSB PDB) Chemical and physical data Formula C16H20FN3O4 Molar mass 337.346 g/mol g·mol−1 3D model ( JSmol) Interactive image Density 1.40 g/cm3 Melting point 135 °C (275 °F) Boiling point 140 °C (284 °F) (decomposes) Solubility in water 3 mg/mL (20 °C) SMILES O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3 InChI InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 Y Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N Y  NY  (what is this?)   (verify)

Infobox drug/testcases8 INN: Linezolid Clinical data Pronunciation /njuːˈmoʊniə/ Trade names Linospan, Zyvox, Zyvoxam, Zyvoxid Other names Lenzomore AHFS/ Drugs.com Monograph MedlinePlus a602004 License data EU  EMA:  by INN US  DailyMed:  Linezolid US  FDA:  Linezolid Pregnancy category AU: C Dependence liability High Addiction liability Low Routes of administration Intravenous infusion, oral ATC code J01XX08 ( WHO) Pharmacokinetic data Bioavailability ~100% (oral) Protein binding Low (31%) Metabolism Hepatic (50–70%, CYP not involved) Metabolites some stuff Onset of action 1 hr Elimination half-life 4.2–5.4 hours (shorter in children) Duration of action 1 to 3 hr Excretion Nonrenal, renal, and fecal Identifiers IUPAC name (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide CAS Number 165800-03-3 Y PubChem CID 441401 IUPHAR/BPS 1234 DrugBank DB00601 ChemSpider 390139 Y UNII ISQ9I6J12J KEGG D00947 Y ChEMBL ChEMBL126 Y NIAID ChemDB 070944 PDB ligand ZLD ( PDBe, RCSB PDB) Chemical and physical data Formula C16H20FN3O4 Molar mass 337.346 g/mol g·mol−1 3D model ( JSmol) Interactive image Density 1.40 g/cm3 Melting point 135 °C (275 °F) Boiling point 140 °C (284 °F) (decomposes) Solubility in water 3 mg/mL (20 °C) SMILES O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3 InChI InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 Y Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N Y  NY  (what is this?)   (verify)

Purge

English language variants: Licence or License

See also WP:ENGVAR: english language variant of the article

In {{Infobox drug}}: spelling of licence/license. Default is to be en-US: License.

Use new parameter |engvar= for non-default spelling:

Default licenSe (US)

|engvar=en-US licenSe

|engvar=en-UK licenCe

|engvar=en-NZ licenCe

Titletests

The infobox title is a logical result of input:

• {{PAGENAME}} (default)
• |drug_name= (overwrites, eg when PAGENAME is not the INN drugname)
• |INN= (added, when PAGENAME/drug_name is not the INN name)

See Category:Infobox drug articles with non-default infobox title (779)

?

Purge (reduced infobox)

Current infobox title: Diamorphine ( INN)

The new situation required an edit.

Side by side comparison

{{ Infobox drug}}

{{ Infobox drug/sandbox}}

Heroin INN: Diamorphine Clinical data Pronunciation /ˈhɛroʊɪn/ Other names Diamorphine, Diacetylmorphine, Acetomorphine, (Dual) Acetylated morphine, Morphine diacetate AHFS/ Drugs.com heroin Dependence liability Physical: Very high Psychological: Very high Addiction liability Very high Routes of administration Inhalation, transmucosal, intravenous, oral, intranasal, rectal, intramuscular ATC code N07BC06 ( WHO) Legal status Legal status AU: S9 (Prohibited substance) Identifiers IUPAC name (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate CAS Number 561-27-3 Y PubChem CID 5462328 DrugBank DB01452 Y ChemSpider 4575379 Y UNII 8H672SHT8E ChEBI CHEBI:27808 Y ChEMBL ChEMBL459324 Y Chemical and physical data Formula C21H23NO5 Molar mass 369.41 g/mol g·mol−1

Heroin INN: Diamorphine Clinical data Pronunciation /ˈhɛroʊɪn/ Other names Diamorphine, Diacetylmorphine, Acetomorphine, (Dual) Acetylated morphine, Morphine diacetate AHFS/ Drugs.com heroin Dependence liability Physical: Very high Psychological: Very high Addiction liability Very high Routes of administration Inhalation, transmucosal, intravenous, oral, intranasal, rectal, intramuscular ATC code N07BC06 ( WHO) Legal status Legal status AU: S9 (Prohibited substance) Identifiers IUPAC name (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate CAS Number 561-27-3 Y PubChem CID 5462328 DrugBank DB01452 Y ChemSpider 4575379 Y UNII 8H672SHT8E ChEBI CHEBI:27808 Y ChEMBL ChEMBL459324 Y Chemical and physical data Formula C21H23NO5 Molar mass 369.41 g/mol g·mol−1

Lysergide (LSD)

Purge Reduced infobox.

Current infobox title: Lysergic acid diethylamide (pagename, not INN)

New situation would be (adding "(LSD)" is just a liberty I took, to help our readers):

Side by side comparison

{{ Infobox drug}}

{{ Infobox drug/sandbox}}

Lysergic acid diethylamide (LSD) INN: Lysergide Clinical data Other names Acid, LSD, lysergide Dependence liability Low Addiction liability None Routes of administration Oral, etc ATC code none Legal status Legal status AU: S9 (Prohibited substance) CA: Schedule III DE: Anlage I (Authorized scientific use only) NZ: Class A UK: Class A US: Schedule I UN: Psychotropic Schedule I Pharmacokinetic data Metabolism Hepatic Elimination half-life 3–5 hours Excretion Renal Identifiers IUPAC name (6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide CAS Number 50-37-3 PubChem CID 5761 IUPHAR/BPS 17 DrugBank DB04829 ChemSpider 5558 UNII 8NA5SWF92O ChEBI CHEBI:6605 ChEMBL ChEMBL263881 Chemical and physical data Formula C20H25N3O Molar mass 323.440 g·mol−1

Lysergic acid diethylamide (LSD) INN: Lysergide Clinical data Other names Acid, LSD, lysergide Dependence liability Low Addiction liability None Routes of administration Oral, etc ATC code none Legal status Legal status AU: S9 (Prohibited substance) CA: Schedule III DE: Anlage I (Authorized scientific use only) NZ: Class A UK: Class A US: Schedule I UN: Psychotropic Schedule I Pharmacokinetic data Metabolism Hepatic Elimination half-life 3–5 hours Excretion Renal Identifiers IUPAC name (6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide CAS Number 50-37-3 PubChem CID 5761 IUPHAR/BPS 17 DrugBank DB04829 ChemSpider 5558 UNII 8NA5SWF92O ChEBI CHEBI:6605 ChEMBL ChEMBL263881 Chemical and physical data Formula C20H25N3O Molar mass 323.440 g·mol−1

(regular)

• alpha-Methyltryptamine

No need to use |INN=. Note the titletext (mousehover).

Side by side comparison

{{ Infobox drug}}	{{ Infobox drug/sandbox}}
α-Methyltryptamine Clinical data Other names Indopan; IT-290, IT-403, U-14,164E, 3-IT Routes of administration Oral ATC code none Identifiers IUPAC name 2-(1H-indol-3-yl)-1-methyl-ethylamine CAS Number 299-26-3 Chemical and physical data Formula C11H14N2 Molar mass 174.247 g·mol−1	α-Methyltryptamine Clinical data Other names Indopan; IT-290, IT-403, U-14,164E, 3-IT Routes of administration Oral ATC code none Identifiers IUPAC name 2-(1H-indol-3-yl)-1-methyl-ethylamine CAS Number 299-26-3 Chemical and physical data Formula C11H14N2 Molar mass 174.247 g·mol−1

Title

INN

INN=none

INN=sense

INN='none'

The time allocated for running scripts has expired.

The time allocated for running scripts has expired.

The time allocated for running scripts has expired.

INN eq

The time allocated for running scripts has expired.

all

The time allocated for running scripts has expired.